EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Imrecoxib: Advances in Pharmacology and Therapeutics

Yan-Hong Wang, Ling-Ling Zhu, Tian-Lang Li, Quan Zhou iD

Drug Design, Development and Therapy · 2024-05 · Volume 18 · 1711-1725

DOI: 10.2147/dddt.s464485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-05. Verfasst von Yan-Hong Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of Ch…. Hauptthemen laut MEDLINE: Cyclooxygenase 2 Inhibitors, Osteoarthritis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclooxygenase 2 InhibitorsOsteoarthritisHumansAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2Animals

Stichwörter der Autor:innen

cyclooxygenase-2efficacyimrecoxibnon-steroidal anti-inflammatory drugolder adultsosteoarthritissafety

Substanzen

Cyclooxygenase 2 InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2

Autor:innen und Institutionen

  • Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
  • VIP Geriatric Ward, Division of Nursing, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.
  • Department of VIP Care and Geriatric Medicine, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China.

ORCID-Profile: Quan Zhou

Zitieren

APA

Wang, Y. H., Zhu, L. L., Li, T. L., & Zhou, Q. (2024). Imrecoxib: Advances in Pharmacology and Therapeutics. Drug Design, Development and Therapy, Volume 18, 1711-1725. https://doi.org/10.2147/dddt.s464485

Vancouver

Wang YH, Zhu LL, Li TL, Zhou Q. Imrecoxib: Advances in Pharmacology and Therapeutics. Drug Design, Development and Therapy. 2024;Volume 18:1711-1725. doi:10.2147/dddt.s464485

BibTeX
@article{Wang2024,
  author = {Wang, Yan-Hong and Zhu, Ling-Ling and Li, Tian-Lang and Zhou, Quan},
  title = {Imrecoxib: Advances in Pharmacology and Therapeutics},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  volume = {Volume 18},
  pages = {1711--1725},
  doi = {10.2147/dddt.s464485}
}
Kostenlos starten →